Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

5.63

+0.25 (4.65%)

At close: Apr 22, 2026, 4:00 PM EDT

5.65

+0.02 (0.36%)

After-hours: Apr 22, 2026, 4:10 PM EDT

Abeona Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	322	290	254	133	55	50
Market Cap Growth	33.95%	14.10%	91.32%	143.48%	9.04%	-66.84%
Enterprise Value	143.91	110.56	172.82	85.06	8.28	12.59
Last Close Price	5.63	5.27	5.57	5.01	3.08	8.50
PE Ratio	5.55	5.22	-3.59	-1.98	-0.56	-0.39
PS Ratio	53.32	49.84	-	37.97	38.60	16.68
PB Ratio	1.86	1.82	5.77	8.96	2.04	1.18
P/TBV Ratio	2.10	2.19	5.19	7.23	0.91	0.79
P/FCF Ratio	-	-3.44	-4.35	-3.56	-1.25	-0.72
P/OCF Ratio	-	-3.80	-4.54	-3.59	-1.26	-0.76
EV/Sales Ratio	24.73	19.00	-	24.30	5.86	4.20
EV/EBITDA Ratio	-	-1.27	-2.78	-1.90	-0.17	-0.15
EV/EBIT Ratio	-	-1.24	-2.69	-1.80	-0.16	-0.14
EV/FCF Ratio	-	-1.31	-2.96	-2.28	-0.19	-0.18
Debt / Equity Ratio	0.07	0.07	0.37	0.30	0.22	0.18
Debt / EBITDA Ratio	-0.28	-0.29	-0.37	-0.12	-0.16	-0.11
Debt / FCF Ratio	-0.30	-0.30	-0.39	-0.14	-0.17	-0.13
Net Debt / Equity Ratio	-1.04	-1.04	-1.70	-3.16	-1.66	-0.84
Net Debt / EBITDA Ratio	1.86	1.92	1.20	1.04	0.93	0.41
Net Debt / FCF Ratio	1.97	1.97	1.28	1.25	1.02	0.51
Asset Turnover	0.04	0.04	0	0.05	0.02	0.03
Inventory Turnover	1.25	1.25	-	-	-	-
Quick Ratio	6.70	6.70	5.99	4.07	6.73	2.89
Current Ratio	6.93	6.93	6.08	4.15	6.83	3.39
Return on Equity (ROE)	77.57%	70.05%	-216.57%	-260.60%	-114.85%	-117.22%
Return on Assets (ROA)	-55.85%	-54.38%	-74.26%	-73.52%	-70.81%	-77.85%
Return on Invested Capital (ROIC)	-1398.29%	-1361.52%	-2391.47%	-924.58%	-329.39%	-247.10%
Return on Capital Employed (ROCE)	-65.08%	-63.36%	-89.85%	-88.09%	-85.29%	-104.34%
Earnings Yield	22.94%	19.17%	-27.83%	-50.50%	-179.54%	-253.77%
FCF Yield	-27.16%	-29.06%	-22.99%	-28.10%	-79.91%	-139.49%
Buyback Yield / Dilution	-61.12%	-61.12%	-91.99%	-171.96%	-99.65%	-6.24%
Total Shareholder Return	-61.12%	-61.12%	-91.99%	-171.96%	-99.65%	-6.24%

Updated Mar 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q